Daniel Lynch

Affiliations

  • Director at Springworks Therapeutics Inc. (SWTX), 2024-05-17
  • at 2Seventy Bio Inc. (TSVT), 2023-06-15
  • Director at Bluebird Bio Inc. (BLUE), 2021-11-17
  • Large Shareholder, Director at Xilio Therapeutics Inc. (XLO), 2021-10-22
  • Director at Translate Bio Inc. (TBIO), 2021-02-16
  • Director at Omega Alpha Spac (OMEG), 2021-01-07
  • Director at Blueprint Medicines Corp (BPMC), 2020-06-26
  • Director at Surface Oncology Inc. (SURF), 2020-06-12
  • Director at Sesen Bio Inc. (SESN), 2019-06-21
  • Director, Other at Dnib Unwind Inc. (BIND), 2016-08-30
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
BPMC $80.42 12,500 Director 174,342 2018-02-14 Filing
BPMC $73.27 3,996 Director 186,842 2018-02-12 Filing
BPMC $74.31 3,748 Director 190,838 2018-02-12 Filing
BPMC $75.15 5,636 Director 194,586 2018-02-12 Filing
BPMC $75.96 2,590 Director 200,222 2018-02-12 Filing